SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001493152-24-006703
Filing Date
2024-02-14
Accepted
2024-02-14 16:34:51
Documents
5
Effectiveness Date
2024-02-14

Document Format Files

Seq Description Document Type Size
1 forms-8.htm S-8 109308
2 ex5-1.htm EX-5.1 13183
3 ex23-1.htm EX-23.1 3790
4 ex107.htm EX-FILING FEES 14254
5 ex5-1_001.jpg GRAPHIC 29821
  Complete submission text file 0001493152-24-006703.txt   182847
Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Filer) CIK: 0001859007 (see all company filings)

IRS No.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277062 | Film No.: 24639293
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)